Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ADALIMUMAB-AFZB for Psoriasis: Side Effects & Safety Data

Visibly Younger Skin in Weeks

Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.

Discover Synevra

There are 37 adverse event reports in the FDA FAERS database where ADALIMUMAB-AFZB was used for Psoriasis.

Most Reported Side Effects for ADALIMUMAB-AFZB

Side Effect Reports % Deaths Hosp.
Off label use 748 35.8% 30 129
Condition aggravated 533 25.5% 9 107
Drug ineffective 254 12.2% 7 46
Fatigue 231 11.1% 8 50
Arthralgia 190 9.1% 2 32
Pain 170 8.1% 7 30
Injection site pain 159 7.6% 0 13
Drug dose omission by device 116 5.6% 1 9
Nausea 115 5.5% 3 20
Headache 113 5.4% 1 27
Inappropriate schedule of product administration 110 5.3% 3 28
Malaise 109 5.2% 5 31
Abdominal pain 107 5.1% 2 32
Diarrhoea 102 4.9% 2 27
Therapeutic product effect incomplete 93 4.5% 1 21

Other Indications for ADALIMUMAB-AFZB

Crohn's disease (913) Rheumatoid arthritis (337) Hidradenitis (190) Colitis ulcerative (166) Ankylosing spondylitis (153) Psoriatic arthropathy (146) Uveitis (41) Juvenile idiopathic arthritis (38) Product used for unknown indication (18)

Other Drugs Used for Psoriasis

APREMILAST (76,127) SECUKINUMAB (58,471) ADALIMUMAB (56,634) RISANKIZUMAB-RZAA (40,890) ETANERCEPT (30,483) USTEKINUMAB (21,763) IXEKIZUMAB (16,569) GUSELKUMAB (11,736) CERTOLIZUMAB PEGOL (8,179) METHOTREXATE (6,628)

Related Pages

ADALIMUMAB-AFZB Full Profile All Psoriasis Drugs ADALIMUMAB-AFZB Demographics ADALIMUMAB-AFZB Timeline